April 11, 2014 -- 8:30 a.m. - 04/11/14
U.S. stock index futures are indicating a second day of losses. The Dow and S&P 500 are 0.4% below fair value. The NASDAQ is losing 0.7% in early action after suffering its biggest drop since November 2011.
Stocks are poised to extend yesterdays retreat as the biotechnology selloff continues and following a disappointing start to the earnings season for banks. Gilead Sciences is down 1.6% in pre-market trading and Celgene is losing 1.8%.
On the earnings front, shares of JPMorgan are falling 3.8% ahead of the opening bell after the company reported an unexpected decline in first-quarter profit as revenue from securities trading dropped.Economic data is also garnering attention. The producer price index rose more than expected in March, increasing 0.5%, the largest gain since June. In addition, the University of Michigan consumer confidence survey is due out at 9:55 a.m. ET and is expected to tick higher this month to 81.0 from Marchs reading of 80.0.
Meanwhile in China, consumer inflation remained below the governments target in March while factory-gate deflation deepened. In commodities, gold is rising to a two-week high amid a weaker U.S. dollar while copper increases for a second day. WTI crude is down but remains on pace to post a weekly advance.
In fixed-income, Treasury prices are adding to yesterdays rally. The 10-year note is up 8/32 to yield 2.62% and the 30-year bond is higher by 24/32 to yield 3.48%.
This information is obtained from sources and data considered to be reliable, but its accuracy and completeness is not guaranteed by Wells Fargo Advisors.Wells Fargo Advisors is the trade name used by two separate registered broker-dealers: Wells Fargo Advisors, LLC and Wells Fargo Advisors Financial Network, LLC, Members SIPC, non-bank affiliates of Wells Fargo & Company.